Why Travere's Filspari Approval Odds Look Underpriced at $31.59
Travere Therapeutics (TVTX) is trading in a tight range around $31.59 with low-to-moderate volume. Market pricing appears to understate the value of a potential Filspari approval for FSGS. This trade targets a material re-rating on positive regulatory news while keeping a disciplined stop to limit downside if the binary outcome goes the other way.